Investment Analysts’ updated eps estimates for Friday, January 10th:
ABIVAX Société Anonyme (NASDAQ:ABVX) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $33.00 target price on the stock.
Acadia Healthcare (NASDAQ:ACHC) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $64.00 target price on the stock.
First Majestic Silver (NYSE:AG) (TSE:FR) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $11.00 target price on the stock.
Amazon.com (NASDAQ:AMZN) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $285.00 target price on the stock.
Aptose Biosciences (NASDAQ:APTO) (TSE:APS) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $2.00 price target on the stock.
Arhaus (NASDAQ:ARHS) had its outperform rating reissued by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $11.00 price target on the stock.
Avadel Pharmaceuticals (NASDAQ:AVDL) had its buy rating reissued by analysts at HC Wainwright. They currently have a $21.00 price target on the stock, down from their previous price target of $25.00.
Bath & Body Works (NYSE:BBWI) had its hold rating reiterated by analysts at Argus.
Biomea Fusion (NASDAQ:BMEA) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $128.00 target price on the stock.
CG Oncology (NASDAQ:CGON) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $75.00 price target on the stock.
Ciena (NYSE:CIEN) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $95.00 target price on the stock.
Canadian National Railway (NYSE:CNI) (TSE:CNR) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $174.00 price target on the stock.
Cinemark (NYSE:CNK) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $40.00 target price on the stock.
Collegium Pharmaceutical (NASDAQ:COLL) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $50.00 target price on the stock.
CoStar Group (NASDAQ:CSGP) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $83.00 price target on the stock.
Cytokinetics (NASDAQ:CYTK) had its buy rating reissued by analysts at HC Wainwright.
DBV Technologies (NASDAQ:DBVT) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $10.00 target price on the stock.
Precision BioSciences (NASDAQ:DTIL) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $60.00 price target on the stock.
DoubleVerify (NYSE:DV) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $25.00 price target on the stock.
Devon Energy (NYSE:DVN) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $50.00 price target on the stock.
Dyne Therapeutics (NASDAQ:DYN) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $55.00 price target on the stock.
Emergent BioSolutions (NYSE:EBS) had its buy rating reissued by analysts at HC Wainwright. They currently have a $15.00 target price on the stock.
EMX Royalty (NYSEAMERICAN:EMX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $7.00 target price on the stock.
Esperion Therapeutics (NASDAQ:ESPR) had its buy rating reissued by analysts at HC Wainwright.
Getty Images (NYSE:GETY) had its buy rating reiterated by analysts at Benchmark Co.. The firm currently has a $6.00 target price on the stock.
GH Research (NASDAQ:GHRS) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $40.00 price target on the stock.
Alphabet (NASDAQ:GOOGL) had its market perform rating reaffirmed by analysts at JMP Securities.
Granite Point Mortgage Trust (NYSE:GPMT) had its market perform rating reiterated by analysts at JMP Securities.
Getty Realty (NYSE:GTY) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $34.00 price target on the stock.
Hookipa Pharma (NASDAQ:HOOK) had its neutral rating reaffirmed by analysts at HC Wainwright.
IGM Biosciences (NASDAQ:IGMS) had its neutral rating reiterated by analysts at Wedbush. They currently have a $3.00 price target on the stock, down from their previous price target of $22.00.
IGM Biosciences (NASDAQ:IGMS) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $2.00 price target on the stock, down from their previous price target of $48.00.
IGM Biosciences (NASDAQ:IGMS) had its market perform rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $2.00 target price on the stock, down from their previous target price of $21.00.
IMAX (NYSE:IMAX) had its buy rating reaffirmed by analysts at Benchmark Co.. They currently have a $30.00 target price on the stock.
Immunocore (NASDAQ:IMCR) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $71.00 price target on the stock.
Incyte (NASDAQ:INCY) had its neutral rating reissued by analysts at Cantor Fitzgerald.
Inovio Pharmaceuticals (NASDAQ:INO) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $18.00 target price on the stock.
Intuit (NASDAQ:INTU) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $765.00 price target on the stock.
Invivyd (NASDAQ:IVVD) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $9.00 price target on the stock.
Janux Therapeutics (NASDAQ:JANX) had its outperform rating reissued by analysts at William Blair.
J.B. Hunt Transport Services (NASDAQ:JBHT) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $195.00 target price on the stock.
Kamada (NASDAQ:KMDA) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $11.00 target price on the stock.
LGI Homes (NASDAQ:LGIH) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $160.00 target price on the stock.
Mid-America Apartment Communities (NYSE:MAA) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $160.00 target price on the stock.
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its market outperform rating reaffirmed by analysts at JMP Securities. The firm currently has a $427.00 target price on the stock.
MediWound (NASDAQ:MDWD) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $25.00 price target on the stock.
MoonLake Immunotherapeutics (NASDAQ:MLTX) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $100.00 target price on the stock.
ModivCare (NASDAQ:MODV) had its equal weight rating reiterated by analysts at Stephens. The firm currently has a $17.00 price target on the stock, down from their previous price target of $21.00.
NeoGenomics (NASDAQ:NEO) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $19.00 target price on the stock.
Northern Oil and Gas (NYSE:NOG) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $45.00 price target on the stock.
NexPoint Real Estate Finance (NYSE:NREF) had its market perform rating reaffirmed by analysts at JMP Securities.
Onsemi (NASDAQ:ON) had its hold rating reaffirmed by analysts at Truist Financial Co.. The firm currently has a $60.00 price target on the stock, down from their previous price target of $85.00.
Option Care Health (NASDAQ:OPCH) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $30.00 price target on the stock, down from their previous price target of $31.00.
Plains All American Pipeline (NYSE:PAA) had its sector outperform rating reaffirmed by analysts at Scotiabank. The firm currently has a $23.00 price target on the stock.
Phathom Pharmaceuticals (NASDAQ:PHAT) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $28.00 target price on the stock.
Phreesia (NYSE:PHR) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $29.00 price target on the stock.
Palvella Therapeutics (NASDAQ:PVLA) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $38.00 price target on the stock.
Paycor HCM (NASDAQ:PYCR) had its equal weight rating reissued by analysts at Stephens. Stephens currently has a $22.50 price target on the stock, up from their previous price target of $20.00.
Q2 (NYSE:QTWO) had its neutral rating reissued by analysts at Robert W. Baird. They currently have a $99.00 target price on the stock, up from their previous target price of $89.00.
RCI Hospitality (NASDAQ:RICK) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $98.00 target price on the stock.
Avidity Biosciences (NASDAQ:RNA) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $72.00 target price on the stock.
Ross Stores (NASDAQ:ROST) had its equal weight rating reiterated by analysts at Wells Fargo & Company. The firm currently has a $165.00 target price on the stock.
Solid Biosciences (NASDAQ:SLDB) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $16.00 target price on the stock.
Constellation Brands (NYSE:STZ) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $280.00 target price on the stock.
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its neutral rating reiterated by analysts at HC Wainwright.
Turning Point Brands (NYSE:TPB) had its buy rating reaffirmed by analysts at Roth Mkm. They currently have a $70.00 target price on the stock.
Vir Biotechnology (NASDAQ:VIR) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $110.00 price target on the stock.
Verint Systems (NASDAQ:VRNT) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $40.00 price target on the stock.
Williams Companies (NYSE:WMB) had its sector perform rating reaffirmed by analysts at Scotiabank. Scotiabank currently has a $51.00 target price on the stock.
W. P. Carey (NYSE:WPC) had its market perform rating reissued by analysts at JMP Securities.
Yum! Brands (NYSE:YUM) had its neutral rating reissued by analysts at Citigroup Inc.. They currently have a $141.00 price target on the stock, down from their previous price target of $153.00.
Zoom Video Communications (NASDAQ:ZM) had its hold rating reiterated by analysts at Needham & Company LLC.
Zscaler (NASDAQ:ZS) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $240.00 target price on the stock.
Receive News & Ratings for ABIVAX Société Anonyme Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABIVAX Société Anonyme and related companies with MarketBeat.com's FREE daily email newsletter.
